Mathematical modeling of ER-positive breast cancer treatment with AZD9496 and palbociclib (Q2129968): Difference between revisions
From MaRDI portal
Added link to MaRDI item. |
ReferenceBot (talk | contribs) Changed an Item |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.3934/math.2020223 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W3014533183 / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Mathematical modeling of tumor growth: the MCF-7 breast cancer cell line / rank | |||
Normal rank | |||
Latest revision as of 18:20, 28 July 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mathematical modeling of ER-positive breast cancer treatment with AZD9496 and palbociclib |
scientific article |
Statements
Mathematical modeling of ER-positive breast cancer treatment with AZD9496 and palbociclib (English)
0 references
25 April 2022
0 references
breast cancer
0 references
MCF-7 cell line
0 references
cancer treatment
0 references
mathematical modeling
0 references
mathematical simulation
0 references
